Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2012-06-30
2019-07-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
Exclusion Criteria
* pregnant
* not able to use the Smart charger
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sequana Medical N.V.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea De Gottardi, Privatdozent
Role: PRINCIPAL_INVESTIGATOR
Insel Gruppe AG, University Hospital Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uniklinik Dresden
Dresden, , Germany
Klinikum der Johann Wolfgang Goethe Universität
Frankfurt, , Germany
Universitätsklinikum des Saarlandes
Homburg/Saar, , Germany
Universitätsklinikum Jena
Jena, , Germany
St Georg Klinik
Leipzig, , Germany
Universitätsklinikum Leipzig, AöR
Leipzig, , Germany
Medizinische Klinik, Universitätsmedizin Mannheim
Mannheim, , Germany
Uniklinik Würzburg
Würzburg, , Germany
Hosptial Universitari Vall d'Hebron
Barcelona, , Spain
Inselspital
Bern, , Switzerland
University Clinic of Geneva (HUG)
Geneva, , Switzerland
The London Clinic, The liver centre
London, , United Kingdom
Freeman Hospital Newcastle on Tyne
Newcastle upon Tyne, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, Storni F, Banz V, Babatz J, Vargas V, Geier A, Engelmann C, Herber A, Trepte C, Capel J, De Gottardi A. Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pump. Liver Int. 2022 Oct;42(10):2247-2259. doi: 10.1111/liv.15337. Epub 2022 Jul 25.
Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, Storni F, Banz V, Babatz J, Vargas V, Geier A, Stallmach A, Engelmann C, Trepte C, Capel J, De Gottardi A. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis. Aliment Pharmacol Ther. 2017 Nov;46(10):981-991. doi: 10.1111/apt.14331. Epub 2017 Sep 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-AAR-004
Identifier Type: -
Identifier Source: org_study_id